ICD-10-CM Billable Code

C81.16

Nodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes

Clinical Classification Guidelines

Medical Intelligence & Overview

Nodular sclerosis Hodgkin lymphoma is a specific type of Hodgkin lymphoma, a cancer that originates in the lymphatic system. When it involves the intrapelvic lymph nodes, it affects the lymph nodes located within the pelvis. This form of lymphoma is most commonly diagnosed in young adults and is characterized by the presence of distinctive nodular tissue patterns in affected lymph nodes. Understanding this condition involves exploring its causes, symptoms, diagnosis, and treatment options.

Causes & Symptoms

Clinical Causes: The exact cause of Hodgkin lymphoma remains unknown, but it is believed to involve a combination of genetic factors and environmental influences. Previous exposure to certain viruses, particularly the Epstein-Barr virus (EBV), has been associated with a higher risk. Family history of Hodgkin lymphoma or other lymphatic cancers may increase susceptibility. Immunodeficiency states can also be a contributing factor.

Key Symptoms: Swelling or painless enlargement of lymph nodes in the pelvic region, which may be felt as a lump or mass. Persistent fatigue or fatigue that worsens over time. Unexplained weight loss shouldering a significant reduction in weight over weeks or months. Fever that is not caused by an infection. Night sweats, often severe enough to soak clothing or bedding. Itching all over the body without a clear cause. Discomfort or pain in the pelvic area, especially after consuming alcohol. Sometimes, symptoms related to pressure on nearby organs or tissues, such as difficulty urinating or bowel movements.

Diagnostic & Treatment

Diagnosis Path: Diagnostic procedures for nodular sclerosis Hodgkin lymphoma typically include a combination of physical examinations, imaging tests, and laboratory procedures: - **Physical exam:** Checking for swollen lymph nodes or other signs. - **Imaging studies:** PET scans and CT scans to identify affected areas and assess the extent of the disease. - **Biopsy:** Removing a sample tissue from the enlarged lymph nodes for microscopic examination to confirm the presence of Hodgkin lymphoma cells. - **Blood tests:** To evaluate overall health and organ function. - **Additional tests:** Bone marrow biopsy may be necessary if systemic involvement is suspected. Confirming the diagnosis is crucial to determine the most effective treatment approach.

Treatment Protocols: Treatment strategies for nodular sclerosis Hodgkin lymphoma targeting intrapelvic lymph nodes usually involve chemotherapy, radiation therapy, or a combination of both. Specific options include: - **Chemotherapy:** Using drugs to destroy cancerous cells, often employing regimens like ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine). - **Radiation therapy:** Targeted radiation to affected pelvic lymph nodes to eliminate remaining cancer cells. - **Immunotherapy:** Emerging treatments that use the body's immune system to fight cancer. - **Stem cell transplant:** Considered in cases where the disease relapses or does not respond to initial treatments. The choice of therapy depends on the stage of the lymphoma, overall health, and specific patient factors. Regular follow-up care is essential to monitor for potential relapse or side effects of treatment.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C81.16 a billable ICD-10 code?
Yes, C81.16 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C81.16?
Clinical documentation must specify the nature of Nodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

nodular sclerosis intrapelvic lymph nodes hodgkin